Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Toi

Showing results (11-20 of 222) with videos related to

Pageof 23
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1996
[Breast cancer angiogenesis]M Toi, T Tominaga
Oncology Reports|May 9, 1998
Relationship between matrix metalloproteinase expression and tumor angiogenesis in human breast carcinomaT Kurizaki, M Toi, T Tominaga
Oncology Reports|May 25, 2011
Increase in the circulating level of hepatocyte growth-factor in breast-cancer patients with distant metastasesT Taniguchi, M Toi, T Tominaga
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 9, 1998
[New molecular target of cancer therapy--angiogenesis regulator VEGF]M Toi, T Ueno, T Tominaga
Oncology Reports|February 22, 2001
Circulating levels of endostatin in cancer patientsK Kuroi, C Tanaka, M Toi
Breast Cancer Research and Treatment|March 5, 1999
Metalloproteinases and tissue inhibitors of metalloproteinasesM Toi, S Ishigaki, T Tominaga
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1994
[Feasibility of adjuvant high-dose CAF (cyclophosphamide, adriamycin, 5-FU) therapy for primary breast cancer patients]M Toi, K Hayashi, T Tominaga
Breast Cancer (Tokyo, Japan)|December 15, 2000
The predictive value of angiogenesis for adjuvant therapy in breast cancerM Toi, H Bando, K Kuroi
International Journal of Cancer|September 30, 1993
Tumor angiogenesis is an independent prognostic indicator in primary breast carcinomaM Toi, J Kashitani, T Tominaga
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
Circulating soluble Fas concentration in breast cancer patientsT Ueno, M Toi, T Tominaga
Pageof 23

Showing results (11-20 of 222) with videos related to

Sort By:
Pageof 23
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1996
[Breast cancer angiogenesis]M Toi, T Tominaga
Oncology Reports|May 9, 1998
Relationship between matrix metalloproteinase expression and tumor angiogenesis in human breast carcinomaT Kurizaki, M Toi, T Tominaga
Oncology Reports|May 25, 2011
Increase in the circulating level of hepatocyte growth-factor in breast-cancer patients with distant metastasesT Taniguchi, M Toi, T Tominaga
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 9, 1998
[New molecular target of cancer therapy--angiogenesis regulator VEGF]M Toi, T Ueno, T Tominaga
Oncology Reports|February 22, 2001
Circulating levels of endostatin in cancer patientsK Kuroi, C Tanaka, M Toi
Breast Cancer Research and Treatment|March 5, 1999
Metalloproteinases and tissue inhibitors of metalloproteinasesM Toi, S Ishigaki, T Tominaga
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1994
[Feasibility of adjuvant high-dose CAF (cyclophosphamide, adriamycin, 5-FU) therapy for primary breast cancer patients]M Toi, K Hayashi, T Tominaga
Breast Cancer (Tokyo, Japan)|December 15, 2000
The predictive value of angiogenesis for adjuvant therapy in breast cancerM Toi, H Bando, K Kuroi
International Journal of Cancer|September 30, 1993
Tumor angiogenesis is an independent prognostic indicator in primary breast carcinomaM Toi, J Kashitani, T Tominaga
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
Circulating soluble Fas concentration in breast cancer patientsT Ueno, M Toi, T Tominaga
Pageof 23